Related Experiment Video
Updated: May 5, 2026

Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish
Published on: October 27, 2017
Qiming granules regulate Müller cell pyroptosis and the P2X7R/NLRP3 immune inflammatory pathway in diabetic
Qi Zhou1,2, Min Tang1, Yaping Wang2
1Department of Ophthalmology, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
Introduction:
Müller cell pyroptosis and immune inflammation-induced retinal ganglion cell (RGC) damage are the core pathological markers and potential therapeutic targets for neurodegeneration in early diabetic retinopathy (DR). Qiming Granules (QMG)-recommended by the traditional Chinese medicine guidelines for DR owing to their multi-target immunomodulatory, antioxidant, and microvascular protective effects. This study aimed to clarify the protective effect of QMG on early DR neurodegeneration, reveal their neuroprotective mechanism by regulating the P2X7R/NLRP3 pathway to inhibit Müller cell pyroptosis and immune inflammation, identify the chemical components of QMG and its absorbed components in rat plasma, study the effects of major absorbed components on inhibiting Müller cells pyroptosis and immune inflammatory response, and investigate the potential pharmacodynamic substances of QMG.
Methods:
An in vivo DR neurodegeneration model was established. HE staining, transmission electron microscopy, WB, and ELISA were used for detecting RGC apoptosis, histomorphological changes, P2X7R/NLRP3 expression, and pyroptosis pathway proteins. An in vitro high-glucose-induced Müller cell pyroptosis model was constructed. After activating or inhibiting P2X7R, lactate dehydrogenase levels were measured; moreover, ELISA, WB, and immunofluorescence were performed to examine cell membrane damage, inflammatory factor release, and pyroptosis pathway protein expression. UPLC-Q-Orbitrap HRMS was utilized to characterize the chemical and blood-entering profiles of QMG, aiming to evaluate the inhibitory effects of its main blood components on high glucose-induced Müller cell pyroptosis.
Results:
QG inhibited RGC apoptosis, the P2X7R/NLRP3 pathway, and retinal cell pyroptosis in DR neurodegeneration model rats. In vitro, QMG reduced membrane rupture and pyroptosis pathway protein expression in Müller cells by suppressing the P2X7R/NLRP3 pathway, ultimately inhibiting Müller cell pyroptosis and immune-inflammatory responses. Nine of the 70 compounds identified in QMG were absorbed into the bloodstream. The main absorbed components, astragaloside IV and puerarin, effectively mitigated high glucose-induced Müller cell pyroptosis, with astragaloside IV exhibiting a more pronounced effect.
Conclusions:
QMG mitigated Müller cell pyroptosis and inflammatory responses by regulating the P2X7R/NLRP3 pathway, thereby inhibiting early neurodegeneration in DR. Astragaloside IV and puerarin absorbed into systemic circulation, significantly attenuated high glucose-induced pyroptosis, and suppressed immunoinflammatory responses in Müller cells.
Insights
Qiming Granules (QMG) protect against diabetic retinopathy (DR) by inhibiting Müller cell pyroptosis and inflammation via the P2X7R/NLRP3 pathway. Key absorbed components, astragaloside IV and puerarin, demonstrate significant neuroprotective effects.
Area of Science:
- Ophthalmology and Vision Science
- Neuroscience
- Pharmacology
Background:
- Diabetic retinopathy (DR) involves Müller cell pyroptosis and inflammation, leading to retinal ganglion cell (RGC) damage.
- Qiming Granules (QMG) are recommended for DR due to their immunomodulatory, antioxidant, and vascular protective properties.
Purpose of the Study:
- To investigate the protective effects of QMG on early DR neurodegeneration.
- To elucidate the mechanism of QMG in inhibiting Müller cell pyroptosis and inflammation via the P2X7R/NLRP3 pathway.
- To identify QMG's absorbed components and evaluate their therapeutic potential.
Main Methods:
- Established in vivo DR and in vitro high-glucose-induced Müller cell pyroptosis models.
- Utilized HE staining, electron microscopy, Western blot, ELISA, and immunofluorescence to assess RGC apoptosis, histomorphology, and pyroptosis markers.
- Employed UPLC-Q-Orbitrap HRMS to identify QMG components in rat plasma and evaluate their effects on Müller cells.
Main Results:
- QMG significantly inhibited RGC apoptosis and pyroptosis in DR rats by suppressing the P2X7R/NLRP3 pathway.
- In vitro, QMG reduced Müller cell membrane damage and inflammatory factor release, inhibiting pyroptosis.
- Nine QMG compounds were absorbed; astragaloside IV and puerarin showed potent inhibition of high glucose-induced Müller cell pyroptosis.
Conclusions:
- QMG effectively mitigates Müller cell pyroptosis and inflammation, thereby protecting against early DR neurodegeneration.
- The P2X7R/NLRP3 pathway is a key target for QMG's neuroprotective effects in DR.
- Astragaloside IV and puerarin are significant pharmacodynamic components of QMG, offering therapeutic potential for DR.

